Cargando…

Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study

BACKGROUND: Reduction of proteinuria and blood pressure (BP) with blockers of the renin-angiotensin system (RAS) impairs the progression of chronic kidney disease (CKD). The aldosterone antagonist spironolactone has an antiproteinuric effect, but its use is limited by side effects. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boesby, Lene, Elung-Jensen, Thomas, Klausen, Tobias Wirenfeldt, Strandgaard, Svend, Kamper, Anne-Lise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208556/ https://www.ncbi.nlm.nih.gov/pubmed/22073219 http://dx.doi.org/10.1371/journal.pone.0026904

Ejemplares similares

Eplerenone Attenuates Pulse Wave Reflection in Chronic Kidney Disease Stage 3–4 - A Randomized Controlled Study
por: Boesby, Lene, et al.
Publicado: (2013)

Eplerenone use in primary aldosteronism during pregnancy
por: Gunganah, Kirun, et al.
Publicado: (2015)

Beneficial Effects on Arterial Stiffness and Pulse-Wave Reflection of Combined Enalapril and Candesartan in Chronic Kidney Disease - A Randomized Trial
por: Frimodt-Møller, Marie, et al.
Publicado: (2012)

Antiproteinuric and Hyperkalemic Mechanisms Activated by Dual Versus Single Blockade of the RAS in Renovascular Hypertensive Rats
por: Corrêa, José Wilson N., et al.
Publicado: (2021)

The effect of eplerenone on the renin‐angiotensin‐aldosterone system of rats with thyroid dysfunction
por: Dizaye, Kawa, et al.
Publicado: (2019)

Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy
por: Nakano, Yujiro, et al.
Publicado: (2018)

Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study
por: De Nicola, Luca, et al.
Publicado: (2012)

Agoraphobia and panic attacks complicated by primary aldosteronism improved by treatment with eplerenone: a case report
por: Kijima, Reoto, et al.
Publicado: (2023)

Effect of Eplerenone, a Selective Aldosterone Blocker, on the Development of Diabetic Nephropathy in Type 2 Diabetic Rats
por: Ahn, Jae Hee, et al.
Publicado: (2012)

Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings
por: Patel, Kishan A, et al.
Publicado: (2014)

Is the Antiproteinuric Effect of Cyclosporine A Independent of Its Immunosuppressive Function in T Cells?
por: Zhang, Bin, et al.
Publicado: (2012)

Eplerenone ethanol solvate
por: Yang, Qian, et al.
Publicado: (2008)

A Patient with Bilateral Primary Aldosteronism Refractory to Oral Eplerenone Who Responded to Esaxerenone with Increased Renin Activity
por: Okamura, Keisuke, et al.
Publicado: (2020)

Evaluation of antiproteinuric and hepato-renal protective activities of propolis in paracetamol toxicity in rats
por: El Menyiy, Nawal, et al.
Publicado: (2018)

Effect of systemic arterial hypertension and use of antiproteinuric drug in induction therapy for lupus nephritis
por: Matta, Eduardo Grecco, et al.
Publicado: (2020)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
por: Kapoor, Kapil G., et al.
Publicado: (2015)

Eplerenone: The Multifaceted Drug in Cardiovascular Pharmacology
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

Collagen turnover profiles in chronic kidney disease
por: Rasmussen, Daniel Guldager Kring, et al.
Publicado: (2019)

Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR
por: Trimarchi, H., et al.
Publicado: (2014)

Role of the eNOS-NO System in Regulating the Antiproteinuric Effects of VEGF Receptor 2 Inhibition in Diabetes
por: Advani, Andrew, et al.
Publicado: (2013)

Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease
por: Capelli, Irene, et al.
Publicado: (2023)

Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis
por: Kuo, Ko-Lin, et al.
Publicado: (2015)

Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy
por: Warnock, David G, et al.
Publicado: (2015)

Paricalcitol as an Antiproteinuric Agent Can Result in the Deterioration of Renal and Heart Function in a Patient with Fabry Disease
por: Keber, Tajda, et al.
Publicado: (2017)

Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKD
por: Wouda, Rosa D, et al.
Publicado: (2021)

Eplerenone Treatment in Chronic Central Serous Chorioretinopathy
por: Iqbal, Faisal, et al.
Publicado: (2021)

The role of aldosterone blockade in murine lupus nephritis
por: Monrad, Seetha U, et al.
Publicado: (2008)

Silencing of Renal DNaseI in Murine Lupus Nephritis Imposes Exposure of Large Chromatin Fragments and Activation of Toll Like Receptors and the Clec4e
por: Thiyagarajan, Dhivya, et al.
Publicado: (2012)

Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone
por: LEHMANN-HORN, FRANK, et al.
Publicado: (2012)

Possible dose-dependent effect of eplerenone on intraocular pressure
por: Razavi, Seyedeh Mehrsa Sadat, et al.
Publicado: (2023)

Aldosterone and Its Blockade: A Cardiovascular and Renal Perspective
por: Lahera, V., et al.
Publicado: (2006)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Infant outcome at four years of age after intrapartum sampling of scalp blood lactate for fetal assessment. A cohort study
por: Wiberg, Nana, et al.
Publicado: (2018)

The Influence of Ionizing Radiation, Temperature, and Light on Eplerenone in the Solid State
por: Dettlaff, Katarzyna, et al.
Publicado: (2014)

Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
por: Chatziralli, Irini, et al.
Publicado: (2018)

Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
por: Sadda, Srinivas R.
Publicado: (2020)

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability
por: Khan, Muhammad Ayub, et al.
Publicado: (2021)

Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
por: Anderson, William J., et al.
Publicado: (2022)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

Endoscopic ultrasound for staging of colonic cancer proximal to the rectum: A systematic review and meta-analysis
por: Malmstrøm, Marie Louise, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_te96p63o128vl93u4d436u2h16